Caprolactam Chemicals Ltd
Caprolactam Chemicals Limited was promoted as Vamotiwala Chemicals Industries Limited as a small scale industry in the year 1992. The company specializes in the manufacturing of industrial chemicals like Glycol Ethers and Ethylene Oxide Condensate Emulsifiers. Caprolactam Chemicals has customer base only in India.
- Market Cap ₹ 24.6 Cr.
- Current Price ₹ 53.5
- High / Low ₹ 76.9 / 44.5
- Stock P/E 98.4
- Book Value ₹ 12.1
- Dividend Yield 0.00 %
- ROCE 40.2 %
- ROE 62.6 %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 1.37% over last quarter.
Cons
- Stock is trading at 4.41 times its book value
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2.80 | 3.38 | 3.92 | 2.85 | 4.88 | 3.23 | 4.07 | 5.19 | 6.51 | 6.31 | 2.07 | 9.84 | 7.74 | |
2.49 | 2.71 | 4.03 | 2.46 | 4.05 | 2.76 | 3.18 | 3.31 | 3.99 | 4.14 | 2.64 | 5.17 | 5.53 | |
Operating Profit | 0.31 | 0.67 | -0.11 | 0.39 | 0.83 | 0.47 | 0.89 | 1.88 | 2.52 | 2.17 | -0.57 | 4.67 | 2.21 |
OPM % | 11.07% | 19.82% | -2.81% | 13.68% | 17.01% | 14.55% | 21.87% | 36.22% | 38.71% | 34.39% | -27.54% | 47.46% | 28.55% |
0.08 | 0.05 | 0.01 | -0.15 | 0.40 | 0.01 | 0.07 | 0.07 | 0.06 | 0.09 | 0.41 | 0.02 | 0.14 | |
Interest | 0.00 | 0.00 | 0.00 | 0.06 | 0.11 | 0.12 | 0.19 | 0.34 | 0.30 | 0.30 | 0.28 | 0.57 | 0.53 |
Depreciation | 0.25 | 0.22 | 0.19 | 0.23 | 0.51 | 0.47 | 0.57 | 0.97 | 1.02 | 1.07 | 1.03 | 1.15 | 1.55 |
Profit before tax | 0.14 | 0.50 | -0.29 | -0.05 | 0.61 | -0.11 | 0.20 | 0.64 | 1.26 | 0.89 | -1.47 | 2.97 | 0.27 |
Tax % | 7.14% | 16.00% | 6.90% | 0.00% | 14.75% | 0.00% | 15.00% | 23.44% | 24.60% | 26.97% | 12.93% | 14.14% | |
0.13 | 0.42 | -0.27 | -0.06 | 0.52 | -0.12 | 0.17 | 0.50 | 0.95 | 0.65 | -1.28 | 2.55 | 0.25 | |
EPS in Rs | 0.28 | 0.91 | -0.59 | -0.13 | 1.13 | -0.26 | 0.37 | 1.09 | 2.07 | 1.41 | -2.78 | 5.54 | 0.54 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 19% |
3 Years: | 15% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | 20% |
5 Years: | 72% |
3 Years: | 39% |
TTM: | -90% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 41% |
3 Years: | 13% |
1 Year: | -7% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 20% |
3 Years: | 17% |
Last Year: | 63% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 |
Reserves | -3.23 | -2.81 | -3.08 | -3.13 | -2.61 | -2.73 | -2.56 | -2.06 | -1.10 | -0.52 | -1.80 | 0.74 | 0.98 |
0.53 | 0.02 | 0.09 | 0.82 | 0.95 | 1.37 | 1.89 | 3.58 | 2.45 | 2.15 | 3.76 | 5.69 | 5.70 | |
0.53 | 0.40 | 0.52 | 1.15 | 0.98 | 1.10 | 2.35 | 1.29 | 1.16 | 0.97 | 3.77 | 0.49 | 0.82 | |
Total Liabilities | 2.42 | 2.20 | 2.12 | 3.43 | 3.91 | 4.33 | 6.27 | 7.41 | 7.11 | 7.20 | 10.33 | 11.52 | 12.10 |
1.60 | 1.38 | 1.19 | 2.92 | 2.96 | 3.38 | 3.56 | 6.37 | 6.07 | 5.50 | 5.26 | 10.22 | 9.90 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.96 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.82 | 0.82 | 0.93 | 0.51 | 0.95 | 0.95 | 2.71 | 1.04 | 1.04 | 1.70 | 1.11 | 1.30 | 2.20 | |
Total Assets | 2.42 | 2.20 | 2.12 | 3.43 | 3.91 | 4.33 | 6.27 | 7.41 | 7.11 | 7.20 | 10.33 | 11.52 | 12.10 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.53 | 0.56 | -0.13 | 1.44 | 0.58 | 0.54 | 1.10 | 2.96 | 2.18 | 1.25 | 3.05 | 0.86 | |
-0.11 | 0.00 | 0.00 | -2.16 | -0.56 | -0.89 | -0.75 | -3.78 | -0.73 | -0.48 | -4.75 | -2.14 | |
-0.41 | -0.52 | 0.07 | 0.68 | 0.02 | 0.30 | 0.33 | 0.35 | -1.43 | -0.59 | 1.33 | 1.37 | |
Net Cash Flow | 0.01 | 0.04 | -0.06 | -0.05 | 0.05 | -0.05 | 0.68 | -0.47 | 0.02 | 0.18 | -0.37 | 0.08 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 52.14 | 32.40 | 25.14 | 1.28 | 38.89 | 40.68 | 69.05 | 2.81 | 16.82 | 27.19 | 5.29 | 25.22 |
Inventory Days | 104.29 | 304.17 | 88.78 | 82.64 | 53.85 | |||||||
Days Payable | 43.45 | 861.81 | 799.05 | 344.34 | 173.52 | |||||||
Cash Conversion Cycle | 52.14 | 32.40 | 85.97 | 1.28 | 38.89 | 40.68 | -488.58 | -707.46 | 16.82 | 27.19 | -256.41 | -94.45 |
Working Capital Days | 35.20 | 38.88 | 28.86 | -84.53 | -0.75 | -14.69 | -62.78 | -22.50 | -20.75 | 17.93 | -513.12 | 17.80 |
ROCE % | 6.91% | 27.10% | -17.06% | 11.34% | 27.64% | 0.32% | 10.91% | 19.52% | 25.85% | 19.54% | -18.61% | 40.25% |
Documents
Announcements
- Certificate Under Regulation 40(10) Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015 For The Half Year Ended March 31, 2024 12 Apr
- Certificate Under Regulation 40(10) Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015 For The Half Year Ended March 31, 2024 12 Apr
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 11 Apr
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 11 Apr
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 11 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview [1]
Caprolactam Chemicals is engaged in manufacturing of chemicals and provides Job work services as per customers requirement.
Caprolactam offers ready to use facilities for Contract Manufacturing to the industries like Flavors & Fragrance, Aroma, Pharma & Agro-Chemicals.
Company did 6.5 Cr turnover in FY20 which was jobwork income.